Drugs / Meningococcal Group ACYW135 Conjugate Vaccine
Meningococcal Group ACYW135 Conjugate Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04236960 | Jul 2018 → Sep 2019 | meningococcal infection | Walvax Biotechnology Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal Group ACYW135 Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04236960 ↗ |
| Modality | Vaccine | “Meningococcal Group ACYW135 Conjugate Vaccine” NCT04236960 ↗ |